Related Experiment Video
Updated: Aug 29, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Melatonin and cancer suppression: insights into its effects on DNA methylation
Amirhossein Davoodvandi1,2, Banafsheh Nikfar3, Russel J Reiter4
1Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran.
Abstract:
Melatonin is an important naturally occurring hormone in mammals. Melatonin-mediated biological effects include the regulation of circadian rhythms, which is important for optimal human health. Also, melatonin has a broad range of immunoenhancing actions. Moreover, its oncostatic properties, especially regarding breast cancer, involve a variety cancer-inhibitory processes and are well documented. Due to their promising effects on the prognosis of cancer patients, anti-cancer drugs with epigenetic actions have attracted a significant amount of attention in recent years. Epigenetic modifications of cancers are categorized into three major processes including non-coding RNAs, histone modification, and DNA methylation. Hence, the modification of the latter epigenetic event is currently considered an effective strategy for treatment of cancer patients. Thereby, this report summarizes the available evidence that investigated melatonin-induced effects in altering the status of DNA methylation in different cancer cells and models, e.g., malignant glioma and breast carcinoma. Also, we discuss the role of artificial light at night (ALAN)-mediated inhibitory effects on melatonin secretion and subsequent impact on global DNA methylation of cancer cells.
Insights
Melatonin, a natural hormone, influences circadian rhythms and immunity. This study explores how melatonin affects DNA methylation in cancer cells, including breast cancer and glioma, and the impact of artificial light at night on these processes.
Area of Science:
- Endocrinology
- Cancer Biology
- Epigenetics
Background:
- Melatonin is a crucial mammalian hormone regulating circadian rhythms and immune function.
- Melatonin exhibits oncostatic properties, particularly against breast cancer, through various cancer-inhibitory mechanisms.
- Epigenetic modifications, including DNA methylation, are key targets for novel cancer therapeutics.
Discussion:
- This report reviews evidence on melatonin's effects on DNA methylation in various cancer models.
- It explores how artificial light at night (ALAN) inhibits melatonin secretion.
- The impact of reduced melatonin on global DNA methylation in cancer cells is discussed.
Key Insights:
- Melatonin can alter DNA methylation patterns in cancer cells.
- Epigenetic modifications are a promising avenue for cancer therapy.
- Disruption of melatonin by ALAN may negatively affect cancer epigenetics.
Outlook:
- Further research into melatonin's epigenetic mechanisms in cancer is warranted.
- Targeting melatonin pathways could offer novel cancer treatment strategies.
- Mitigating ALAN exposure may be beneficial for cancer patients.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

